Human PDI b'x (K213-P351) was recombinantly expressed from a pET23 vector with an Nterminal MHHHHHHM tag in E.coli BL21 (DE3) pLysS. Cell were grown using standard minimal media to enable incorporation of single nitrogen or carbon sources for structural biology. These sources (U-13 C-glucose or 15 N ammonium sulphate) can be added in addition to fluorination if required. Cells were grown aseptically until an A 600 of 0.5-0.6 then the fluoroindole of choice (5-or 6-) was added from a 200x stock in DMSO to a final concentration of 60 mg/L of culture. The cells were incubated for a further 15 minutes and then induced with IPTG for 3 hours before harvest. Protein extraction and purification followed standard protocols; human b'x was released from the cells by freeze-thaw commensurate to the pLysS host used. Human b'x was was purified using nickel affinity chromatography followed by ion exchange (Source 30Q) and a final purification step of size exclusion using a Superdex 200. Figure 1 . Amino acid sequence of human PDI b'x with the position of Trp 347 highlighted. The locations of secondary structure elements are depicted by blue rectangles and pink arrows above the sequence representing helices and strands respectively.
ESI Figure 2(d) shows two MS peaks +18
Da apart that are comparable to those observed in ESI 2(c) but here 6-F-indole incorporation is around 55%. Figure 3(a) . 6-F-Trp interactions modelled using the b'x I272A mutant structure (3bj5.pdb).
ESI

ESI Figure 3(b)
. 5-F-Trp interactions modelled using the b'x I272A mutant structure (3bj5.pdb) with a view from below the structure as shown in Figures 1 and 2 . 
